Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 17.4T | 15.9T | 17.5T | 16.8T |
Cost of revenue | 4.8T | 4.3T | 6.8T | 4.2T |
Gross profit | 12.6T | 11.6T | 10.7T | 12.6T |
Operating expense | ||||
Research & development | 3.7T | 3.2T | 4.5T | 3.4T |
Selling general and admin | 2.4T | 2.2T | 3.0T | 2.8T |
Other operating expenses | — | — | — | — |
Operating income | 5.3T | 5.0T | 721.9B | 3.1T |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 686.5B | 699.3B | 702.1B | 714.8B |
Other income expense | -2.1T | -46.7B | 227.9B | 12.7B |
Pretax income | 2.5T | 4.2T | 247.7B | 2.4T |
Tax provision | 651.1B | 720.5B | 140.1B | 652.5B |
Net income | 1.9T | 3.5T | 107.6B | 1.7T |
Basic EPS | — | 1.2 | 0.0 | 0.6 |
Diluted EPS | — | 1.2 | 0.0 | 0.6 |
Basic average shares | — | 2.9T | 2.9T | 2.9T |
Diluted average shares | — | 2.9T | 2.9T | 2.9T |
EBITDA | 7.4T | 7.1T | 4.0T | 7.3T |
Net income from continuing op. | 1.9T | 3.5T | 107.6B | 1.7T |
Minority interests | -2.8B | -8.5B | -5.7B | -5.7B |
Preferred stock dividends | — | — | — | — |